These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17038330)

  • 21. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.
    Doehle BP; Schäfer A; Wiegand HL; Bogerd HP; Cullen BR
    J Virol; 2005 Jul; 79(13):8201-7. PubMed ID: 15956565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-guided analysis of the human APOBEC3-HIV restrictome.
    Aydin H; Taylor MW; Lee JE
    Structure; 2014 May; 22(5):668-84. PubMed ID: 24657093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle.
    Wang X; Dolan PT; Dang Y; Zheng YH
    J Biol Chem; 2007 Jan; 282(3):1585-94. PubMed ID: 17142455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.
    Lackey L; Law EK; Brown WL; Harris RS
    Cell Cycle; 2013 Mar; 12(5):762-72. PubMed ID: 23388464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.
    Stenglein MD; Harris RS
    J Biol Chem; 2006 Jun; 281(25):16837-16841. PubMed ID: 16648136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure.
    Shaban NM; Shi K; Li M; Aihara H; Harris RS
    J Mol Biol; 2016 Jun; 428(11):2307-2316. PubMed ID: 27139641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.
    Kim DY
    Arch Pharm Res; 2015 Apr; 38(4):435-45. PubMed ID: 25408426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Ovine A3Z1 Restriction Properties against Small Ruminant Lentiviruses (SRLVs).
    de Pablo-Maiso L; Glaria I; Crespo H; Nistal-Villán E; Andrésdóttir V; de Andrés D; Amorena B; Reina R
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29149056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.
    Wang X; Li X; Ma J; Zhang L; Ma L; Mi Z; Zhou J; Guo F; Kleiman L; Cen S
    Virus Res; 2014 Oct; 191():30-8. PubMed ID: 25038404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
    Hakata Y; Landau NR
    J Biol Chem; 2006 Dec; 281(48):36624-31. PubMed ID: 17020885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.
    Jónsson SR; Andrésdóttir V
    Viruses; 2013 Jul; 5(8):1934-47. PubMed ID: 23903287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An insight into the dependence of the deamination rate of human APOBEC3F on the length of single-stranded DNA, which is affected by the concentrations of APOBEC3F and single-stranded DNA.
    Wan L; Kamba K; Nagata T; Katahira M
    Biochim Biophys Acta Gen Subj; 2020 Feb; 1864(2):129346. PubMed ID: 30986508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New World feline APOBEC3 potently controls inter-genus lentiviral transmission.
    Konno Y; Nagaoka S; Kimura I; Yamamoto K; Kagawa Y; Kumata R; Aso H; Ueda MT; Nakagawa S; Kobayashi T; Koyanagi Y; Sato K
    Retrovirology; 2018 Apr; 15(1):31. PubMed ID: 29636069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.
    Chen Q; Xiao X; Wolfe A; Chen XS
    J Mol Biol; 2016 Jul; 428(13):2661-70. PubMed ID: 27063502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance.
    Mohammadzadeh N; Love RP; Gibson R; Arts EJ; Poon AFY; Chelico L
    Heliyon; 2019 Apr; 5(4):e01498. PubMed ID: 31025011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.
    Sato K; Takeuchi JS; Misawa N; Izumi T; Kobayashi T; Kimura Y; Iwami S; Takaori-Kondo A; Hu WS; Aihara K; Ito M; An DS; Pathak VK; Koyanagi Y
    PLoS Pathog; 2014 Oct; 10(10):e1004453. PubMed ID: 25330146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytidine deamination induced HIV-1 drug resistance.
    Mulder LC; Harari A; Simon V
    Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5501-6. PubMed ID: 18391217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.
    Harari A; Ooms M; Mulder LC; Simon V
    J Virol; 2009 Jan; 83(1):295-303. PubMed ID: 18945781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.
    Yoshikawa R; Nakano Y; Yamada E; Izumi T; Misawa N; Koyanagi Y; Sato K
    Microbiol Immunol; 2016 Apr; 60(4):272-9. PubMed ID: 26935128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.
    Simon V; Zennou V; Murray D; Huang Y; Ho DD; Bieniasz PD
    PLoS Pathog; 2005 Sep; 1(1):e6. PubMed ID: 16201018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.